If there is one stock which has managed to grab the attention of investors from among micro cap stocks this year in a big way, then it is the Enzolytics Inc (OTCMKTS:ENZC) stock.
The stock was in the middle of a major move yesterday and managed to clock gains of 7%, which took its gains for the week so far to as much as 22%. In this situation, it might be a good idea for investors to take a look at a key recent development. Not too long ago, it was announced by the company that it reached an agreement with Lonza Bioscience by way of which the two companies are going to provide their technologies.
By combining their technologies, the two companies are going to work towards accelerating the production and development of anit-SARS-CoV-2 and anti-HIV monoclonal antibodies that are being produced by Enzolytics. The company has come into major focus this year owing to its work on monoclonal antibodies and it is one of the major factors behind the considerable gains that have been made by the Enzolytics stock so far this year. It might be a good idea for investors to add the stock to their watch lists.
Market Reaction:
On Wednesday, ENZC stock gained 7% at $0.2021 with more than 31.48 million shares, compared to its average volume of 28.93 million shares. The stock had moved within a range of $0.1930 – 0.2201 after opening the trade at $0.1980. Over the past 52-week, the stock has been trading within a range of $0.0003 – 0.9580.
 Stock Hits 20 Cents: How to Trade Now){kind=link}